Business Description
Acticor Biotech SA
ISIN : FR0014005OJ5
Compare
Compare
Traded in other countries / regions
ALACT.France7V7.Germany IPO Date
2021-11-04Description
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.13 | |||||
Equity-to-Asset | 0.03 | |||||
Debt-to-Equity | 19.15 | |||||
Debt-to-EBITDA | -0.44 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -47.7 | |||||
3-Year EPS without NRI Growth Rate | -46 | |||||
3-Year FCF Growth Rate | -41.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.02 | |||||
9-Day RSI | 27.81 | |||||
14-Day RSI | 24.1 | |||||
6-1 Month Momentum % | -2.3 | |||||
12-1 Month Momentum % | -33.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.52 | |||||
Quick Ratio | 1.52 | |||||
Cash Ratio | 0.92 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -88.56 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -2298.56 | |||||
ROA % | -145.09 | |||||
ROIC % | -516.11 | |||||
ROC (Joel Greenblatt) % | -7612.38 | |||||
ROCE % | -258.46 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 30.67 | |||||
EV-to-EBIT | -0.76 | |||||
EV-to-EBITDA | -0.76 | |||||
EV-to-FCF | -0.97 | |||||
Earnings Yield (Greenblatt) % | -131.47 | |||||
FCF Yield % | -104.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Acticor Biotech SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.67 | ||
Beta | 0 | ||
Volatility % | 83.52 | ||
14-Day RSI | 24.1 | ||
14-Day ATR (€) | 0.115779 | ||
20-Day SMA (€) | 0.84615 | ||
12-1 Month Momentum % | -33.85 | ||
52-Week Range (€) | 0.638 - 5.56 | ||
Shares Outstanding (Mil) | 15.51 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Acticor Biotech SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Acticor Biotech SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Acticor Biotech SA Frequently Asked Questions
What is Acticor Biotech SA(FRA:7V7)'s stock price today?
The current price of FRA:7V7 is €0.78. The 52 week high of FRA:7V7 is €5.56 and 52 week low is €0.64.
When is next earnings date of Acticor Biotech SA(FRA:7V7)?
The next earnings date of Acticor Biotech SA(FRA:7V7) is .
Does Acticor Biotech SA(FRA:7V7) pay dividends? If so, how much?
Acticor Biotech SA(FRA:7V7) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |